Inhalerx Ltd Total Liabilities

Latest as of December 2025: AU$2.38 Million AUD ≈ $1.69 Million USD

Inhalerx Ltd total liabilities. Based on the latest financial reports, Inhalerx Ltd (IRX) has total liabilities worth AU$2.38 Million AUD (≈ $1.69 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check IRX asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Inhalerx Ltd (2016–2025)

Total liabilities of Inhalerx Ltd from 2016 to 2025. This chart illustrates how Inhalerx Ltd's total liabilities have evolved over time, based on quarterly financial data.

Inhalerx Ltd Competitors by Total Liabilities

The table below lists competitors of Inhalerx Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Capitan Investment Ltd V:CAI	Canada	CA$1.24 Million
Henderson International Income Trust PLC LSE:HINT	UK	GBX40.28 Million
Anagenics Ltd AU:AN1	Australia	AU$520.80K
Nicoccino Holding AB ST:NICO	Sweden	Skr21.65 Million
ASIA Capital Group Public Company Limited BK:ACAP	Thailand	฿1.94 Billion
Mitra International Resources JK:MIRA	Indonesia	Rp87.64 Billion
JPMorgan Asia Growth & Income plc LSE:JAGI	UK	GBX4.40 Million
Harfang Exploration Inc V:HAR	Canada	CA$297.23K

Liability Composition Analysis (2016–2025)

This chart breaks down Inhalerx Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Inhalerx Ltd total assets.

Liquidity & Leverage Metrics

Inhalerx Ltd Total Liabilities Ratios Explained

Inhalerx Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.58	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.03	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.97	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Inhalerx Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Inhalerx Ltd (2016–2025)

The table below shows the annual total liabilities of Inhalerx Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$2.38 Million ≈ $1.69 Million	+206.96%
2024-12-31	AU$776.37K ≈ $549.33K	-14.82%
2023-12-31	AU$911.41K ≈ $644.88K	+156.51%
2022-12-31	AU$355.32K ≈ $251.41K	+40.25%
2021-12-31	AU$253.34K ≈ $179.26K	-56.33%
2020-12-31	AU$580.10K ≈ $410.46K	+104.53%
2019-12-31	AU$283.63K ≈ $200.69K	-30.54%
2018-12-31	AU$408.33K ≈ $288.92K	-29.54%
2017-12-31	AU$579.51K ≈ $410.04K	-53.54%
2016-12-31	AU$1.25 Million ≈ $882.59K	--

About Inhalerx Ltd

AU:IRX Australia Biotechnology

Market Cap

$4.18 Million

AU$5.91 Million AUD

Market Cap Rank

#28843 Global

#1545 in Australia

Share Price

AU$0.02

Change (1 day)

+4.35%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$0.39